To investigate whether mitochondrial biogenesis affects SIRT6's resistance to cholestatic liver disease, we administered AICAR to liver-specific Sirt6 knockout mice to activate the AMPK/PGC-1α pathway, or used KNI-1 to activate NRF2. This evidence concerns the gene SIRT6 and Cholestatic liver disease.